Abstract:COVID-19 is the latest zoonotic RNA virus epidemic of concern. Learning how it began and spread will help to determine how to reduce the risk of future events. We review major RNA virus outbreaks since 1967 to identify common features and opportunities to prevent emergence, including ancestral viral origins in birds, bats, and other mammals; animal reservoirs and intermediate hosts; and pathways for zoonotic spillover and community spread, leading to local, regional, or international outbreaks. The increasing scientific evidence concerning the origins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is most consistent with a zoonotic origin and a spillover pathway from wildlife to people via wildlife farming and the wildlife trade. We apply what we know about these outbreaks to identify relevant, feasible, and implementable interventions. We identify three primary targets for pandemic prevention and preparedness: first, smart surveillance coupled with epidemiological risk assessment across wildlife-livestock-human (One Health) spillover interfaces; second, research to enhance pandemic preparedness and expedite development of vaccines and therapeutics; and third, strategies to reduce underlying drivers of spillover risk and spread and reduce the influence of misinformation. For all three, continued efforts to improve and integrate biosafety and biosecurity with the implementation of a One Health approach are essential. We discuss new models to address the challenges of creating an inclusive and effective governance structure, with the necessary stable funding for cross-disciplinary collaborative research. Finally, we offer recommendations for feasible actions to close the knowledge gaps across the One Health continuum and improve preparedness and response in the future.

Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer.

Emerging viruses and current strategies for vaccine intervention

A Game of Infection – Song of Respiratory Viruses and Interferons

Host and viral determinants of influenza A virus species specificity

Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases

Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections

Influenza: old and new threats

Emerging Infectious Diseases Never End: the Fight Continues.

Uncovering Novel Viral Innate Immune Evasion Strategies: What Has SARS-CoV-2 Taught Us?

[Circulation of virus and interspecies contamination in wild animals]

Respiratory viruses: New frontiers-a Keystone Symposia report

Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks

From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging Pathogens

Mitigating Future Respiratory Virus Pandemics: New Threats and Approaches to Consider

Vaccinia-based Vaccines to Biothreat and Emerging Viruses

Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses

Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies

Predictive Analysis and Countermeasures in Response to COVID-19 Epidemic in 2020-2021

Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses

How Emerging and Re-Emerging Infectious Diseases Challenge Our Understanding of Viral Infections

Defining the q-analogue of a matroid